INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Total Expenditure History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹85 Cr | ₹62 Cr | ₹52 Cr | ₹43 Cr | ₹35 Cr |
What is the latest Total Expenditure of INDO US BIOTECH ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹85 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹35 Cr |
How is Total Expenditure of INDO US BIOTECH Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹85 Cr | 36.87 | |
| Mar2024 | ₹62 Cr | 18.49 | |
| Mar2023 | ₹52 Cr | 21.40 | |
| Mar2022 | ₹43 Cr | 24.73 | |
| Mar2021 | ₹35 Cr | - | |
Compare Total Expenditure of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹206.3 Cr | 3.4% | -22.3% | -47.1% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,560.0 Cr | -3.9% | -15.5% | -11.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,099.2 Cr | -0.4% | -8.6% | -22.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,760.2 Cr | -3% | -13.1% | -24% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹826.5 Cr | -5.5% | -13.6% | -36.6% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹329.9 Cr | -1.1% | -17.4% | -32.6% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 3.4% |
-22.3% |
-47.1% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses